chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria, Weight decreased
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (Lost 8 pounds in the last two weeks), PAIN (Aches), URTICARIA (Hives from head to toe), ASTHENIA (Weakness) and DIARRHOEA (Diarrhea a few times) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills). On 18-Mar-2021, the patient experienced URTICARIA (Hives from head to toe) and RASH (Rash from head to toe). On an unknown date, the patient experienced WEIGHT DECREASED (Lost 8 pounds in the last two weeks), ASTHENIA (Weakness) and DIARRHOEA (Diarrhea a few times). On 18-Mar-2021, PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, WEIGHT DECREASED (Lost 8 pounds in the last two weeks), URTICARIA (Hives from head to toe), ASTHENIA (Weakness), DIARRHOEA (Diarrhea a few times) and RASH (Rash from head to toe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose tolerance test, Maternal exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 36-year-old female patient (gravida 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Abortion (spontaneous abortion in previous 3 pregnancies), Subfertility (used egg fertilization but had spontaneous pregnancy) and Alcohol use (5 to 6 week). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 15-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy.  On 15-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Oct-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Glucose tolerance test: normal (normal) normal. On an unknown date, Ultrasound scan: abnormal (abnormal) before vaccine, 1 fetus has club foot with ankle.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has a prior use of alcohol, 5 to 6 drinks per week.  Estimated date of conception was 25 Sep 2020.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-086234 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086234:pregnancy
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Tooth infection
Clinical narrative: tooth extraction that became infected; whole left side face is swollen; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (tooth extraction that became infected) and SWELLING FACE (whole left side face is swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 039A21A) for COVID-19 vaccination.     The patient's past medical history included Oral surgery (Oral surgery after first dose of vaccine). Concomitant products included METRONIDAZOLE (FLAGYL 250) and CLINDAMYCIN for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced TOOTH INFECTION (tooth extraction that became infected) and SWELLING FACE (whole left side face is swollen). At the time of the report, TOOTH INFECTION (tooth extraction that became infected) and SWELLING FACE (whole left side face is swollen) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No treatment information was provided    This case was linked to MOD-2021-126496, MOD-2021-126496 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: VAERS
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Myalgia, Nausea
Clinical narrative: pain from neck to shoulder and leg on right side; fever around 100.5 degrees Fahrenheit; felt "very tired"; pain from neck to shoulder and leg on right side; nausea; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain from neck to shoulder and leg on right side), MYALGIA (muscle pain), ARTHRALGIA (pain from neck to shoulder and leg on right side), PYREXIA (fever around 100.5 degrees Fahrenheit) and FATIGUE (felt "very tired") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Diverticulitis, Surgery (surgery on Lungs- part of lung was removed,) and Caesarean section. Concurrent medical conditions included COPD, Emphysema and Clot blood. Concomitant products included ATORVASTATIN, MONTELUKAST, ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO) and VITAMINS NOS for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 17-Feb-2021, the patient experienced MYALGIA (muscle pain). On 19-Mar-2021, the patient experienced NAUSEA (nausea). On 20-Mar-2021, the patient experienced NECK PAIN (pain from neck to shoulder and leg on right side), ARTHRALGIA (pain from neck to shoulder and leg on right side), PYREXIA (fever around 100.5 degrees Fahrenheit) and FATIGUE (felt "very tired"). On 19-Feb-2021, MYALGIA (muscle pain) outcome was unknown. On 21-Mar-2021, PYREXIA (fever around 100.5 degrees Fahrenheit), FATIGUE (felt "very tired") and NAUSEA (nausea) had resolved. At the time of the report, NECK PAIN (pain from neck to shoulder and leg on right side) and ARTHRALGIA (pain from neck to shoulder and leg on right side) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: 100.5 (High) 100.5 degrees Fahrenheit..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-054456, US-MODERNATX, INC.-MOD-2021-056898, US-MODERNATX, INC.-MOD-2021-056977 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054456:crosslink US-MODERNATX, INC.-MOD-2021-056898:1st dose case of patient's husband US-MODERNATX, INC.-MOD-2021-056977:2nd dose case of patient's husband
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia
Clinical narrative: pain from neck to shoulder and leg on right side; fever around 100.5 degrees Fahrenheit; felt "very tired"; pain from neck to shoulder and leg on right side; nausea; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain from neck to shoulder and leg on right side), MYALGIA (muscle pain), ARTHRALGIA (pain from neck to shoulder and leg on right side), PYREXIA (fever around 100.5 degrees Fahrenheit) and FATIGUE (felt "very tired") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Diverticulitis, Surgery (surgery on Lungs- part of lung was removed,) and Caesarean section. Concurrent medical conditions included COPD, Emphysema and Clot blood. Concomitant products included ATORVASTATIN, MONTELUKAST, ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO) and VITAMINS NOS for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 17-Feb-2021, the patient experienced MYALGIA (muscle pain). On 19-Mar-2021, the patient experienced NAUSEA (nausea). On 20-Mar-2021, the patient experienced NECK PAIN (pain from neck to shoulder and leg on right side), ARTHRALGIA (pain from neck to shoulder and leg on right side), PYREXIA (fever around 100.5 degrees Fahrenheit) and FATIGUE (felt "very tired"). On 19-Feb-2021, MYALGIA (muscle pain) outcome was unknown. On 21-Mar-2021, PYREXIA (fever around 100.5 degrees Fahrenheit), FATIGUE (felt "very tired") and NAUSEA (nausea) had resolved. At the time of the report, NECK PAIN (pain from neck to shoulder and leg on right side) and ARTHRALGIA (pain from neck to shoulder and leg on right side) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, Body temperature: 100.5 (High) 100.5 degrees Fahrenheit..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-054456, US-MODERNATX, INC.-MOD-2021-056898, US-MODERNATX, INC.-MOD-2021-056977 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054456:crosslink US-MODERNATX, INC.-MOD-2021-056898:1st dose case of patient's husband US-MODERNATX, INC.-MOD-2021-056977:2nd dose case of patient's husband
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Paraesthesia, Tenderness, Vaccination site scab
Clinical narrative: scab at the injection site; light headed/woozy; tingling in her legs; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), DIZZINESS (light headed/woozy), PARAESTHESIA (tingling in her legs) and VACCINATION SITE SCAB (scab at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (Type 2). Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA) for Diabetes.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced TENDERNESS (tenderness). On 22-Mar-2021, the patient experienced DIZZINESS (light headed/woozy) and PARAESTHESIA (tingling in her legs). On 23-Mar-2021, the patient experienced VACCINATION SITE SCAB (scab at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Pain in extremity, at a dose of UNK dosage form. At the time of the report, TENDERNESS (tenderness), DIZZINESS (light headed/woozy), PARAESTHESIA (tingling in her legs) and VACCINATION SITE SCAB (scab at the injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature, Bone pain, Chills, Decreased appetite
Clinical narrative: bone aches in general, all the body; Has no appetite; armpits hurt; chills; feels exhausted; has had fever of 100.1; lots of headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), HEADACHE (lots of headache) and CHILLS (chills) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Prostate cancer stage IV, Lymphoma (Two lymphoma at base of her hip) and Gastritis. Concomitant products included OMEPRAZOLE for Gastritis, ABIRATERONE ACETATE (ZYTIGA) and PREDNISONE for an unknown indication.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (lots of headache). On 22-Mar-2021, the patient experienced BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), CHILLS (chills), FATIGUE (feels exhausted) and PYREXIA (has had fever of 100.1). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg one pill. At the time of the report, BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), HEADACHE (lots of headache), CHILLS (chills), FATIGUE (feels exhausted) and PYREXIA (has had fever of 100.1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Body temperature: 100.1 f (High) 100.1 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: bone aches in general, all the body; Has no appetite; armpits hurt; chills; feels exhausted; has had fever of 100.1; lots of headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), HEADACHE (lots of headache) and CHILLS (chills) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Prostate cancer stage IV, Lymphoma (Two lymphoma at base of her hip) and Gastritis. Concomitant products included OMEPRAZOLE for Gastritis, ABIRATERONE ACETATE (ZYTIGA) and PREDNISONE for an unknown indication.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (lots of headache). On 22-Mar-2021, the patient experienced BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), CHILLS (chills), FATIGUE (feels exhausted) and PYREXIA (has had fever of 100.1). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg one pill. At the time of the report, BONE PAIN (bone aches in general, all the body), DECREASED APPETITE (Has no appetite), AXILLARY PAIN (armpits hurt), HEADACHE (lots of headache), CHILLS (chills), FATIGUE (feels exhausted) and PYREXIA (has had fever of 100.1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Body temperature: 100.1 f (High) 100.1 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Electrocardiogram, Heart rate, Tachycardia
Clinical narrative: Tachycardia (HR 116 BPM); Severe High Blood Pressure (170/90 mmHg); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Severe High Blood Pressure (170/90 mmHg)) and TACHYCARDIA (Tachycardia (HR 116 BPM)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 024m20a) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (allergy to clindamycin and zithromax) and Blood pressure since 01-May-2019. Concomitant products included METOPROLOL from 01-May-2019 to an unknown date and AMLODIPINE BESILATE (NORVASC) from 01-Jun-2019 to an unknown date for an unknown indication.   On 17-Mar-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (Severe High Blood Pressure (170/90 mmHg)). On 31-Mar-2021 at 10:00 PM, the patient experienced TACHYCARDIA (Tachycardia (HR 116 BPM)). On 01-Apr-2021, BLOOD PRESSURE INCREASED (Severe High Blood Pressure (170/90 mmHg)) and TACHYCARDIA (Tachycardia (HR 116 BPM)) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Blood pressure measurement: (High) 170/90 mm/Hg. On 17-Mar-2021, Heart rate: (High) 116 bpm. On an unknown date, Blood pressure measurement: 160/90 (High) 160/90 mm/Hg. On an unknown date, Electrocardiogram: tachycardia (abnormal) Tachycardia. On an unknown date, Heart rate: 120 (High) 120 bpm.         No treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.   This case was linked to MOD-2021-054522 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Followup information was received on 11 May 2021 wherein patient contact details, conditions and dose details were added.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Sweating; Muscle pain; Fever(100.6); This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), MYALGIA (Muscle pain) and PYREXIA (Fever(100.6)) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), MYALGIA (Muscle pain) and PYREXIA (Fever(100.6)). At the time of the report, HYPERHIDROSIS (Sweating), MYALGIA (Muscle pain) and PYREXIA (Fever(100.6)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Body temperature: 100.6.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: niece who is pregnant and got both shots of the Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (niece who is pregnant and got both shots of the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (niece who is pregnant and got both shots of the Moderna vaccine). At the time of the report, EXPOSURE DURING PREGNANCY (niece who is pregnant and got both shots of the Moderna vaccine) outcome was unknown.            No concomitant medications reported. no treatment details reported. Reporter informed that the due date is in Jun 2021.   This case was linked to MOD21-060896, MOD21-060411, MOD21-060585 (Linked Report).; Sender's Comments:  MOD21-060896:cross link case MOD21-060411:cross link  case MOD21-060585:cross link case
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Reb blotch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Reb blotch at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE RASH (Reb blotch at the injection site). At the time of the report, VACCINATION SITE RASH (Reb blotch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications are not provided by the reporter. No treatment drugs are not provided by reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Lacrimation increased
Clinical narrative: at injection site her skin did not feel like skin; horrific pain in arm; at injection site her skin did not feel like skin, noticed swelling; chills; chronic fatigue, feeling being exhausted; headache; dizziness; eyes watering; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (dizziness), LACRIMATION INCREASED (eyes watering), SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm) and VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), LACRIMATION INCREASED (eyes watering), SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm), VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling), CHILLS (chills), FATIGUE (chronic fatigue, feeling being exhausted) and HEADACHE (headache). At the time of the report, DIZZINESS (dizziness) and LACRIMATION INCREASED (eyes watering) had resolved, SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm), VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling) and FATIGUE (chronic fatigue, feeling being exhausted) outcome was unknown and CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin disorder, Vaccination site swelling
Clinical narrative: at injection site her skin did not feel like skin; horrific pain in arm; at injection site her skin did not feel like skin, noticed swelling; chills; chronic fatigue, feeling being exhausted; headache; dizziness; eyes watering; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (dizziness), LACRIMATION INCREASED (eyes watering), SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm) and VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), LACRIMATION INCREASED (eyes watering), SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm), VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling), CHILLS (chills), FATIGUE (chronic fatigue, feeling being exhausted) and HEADACHE (headache). At the time of the report, DIZZINESS (dizziness) and LACRIMATION INCREASED (eyes watering) had resolved, SKIN DISORDER (at injection site her skin did not feel like skin), PAIN IN EXTREMITY (horrific pain in arm), VACCINATION SITE SWELLING (at injection site her skin did not feel like skin, noticed swelling) and FATIGUE (chronic fatigue, feeling being exhausted) outcome was unknown and CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 08-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnancy). On 08-Jan-2021, EXPOSURE DURING PREGNANCY (pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. The start date of pregnancy was reported as 02-JUL-2020. No treatment information was provided. Action taken with mRNA-1273 in response to events was not applicable.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: pulse rate was 114; pulse rate was 118; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (pulse rate was 118) and HEART RATE INCREASED (pulse rate was 114) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thrombocytopenia.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEART RATE INCREASED (pulse rate was 118). On 23-Mar-2021, the patient experienced HEART RATE INCREASED (pulse rate was 114). At the time of the report, HEART RATE INCREASED (pulse rate was 118) and HEART RATE INCREASED (pulse rate was 114) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Heart rate: 118 (High) pulse rate was 118. On 23-Mar-2021, Heart rate: 114 (High) pulse rate was 114.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: rash on leg, itching/itching rash on leg; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash on leg, itching/itching rash on leg) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced RASH PRURITIC (rash on leg, itching/itching rash on leg). At the time of the report, RASH PRURITIC (rash on leg, itching/itching rash on leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment for the event included Steroid injection received on 18 Mar 2021.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-148682 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Follow up received on 19 MAY 2021 and added Reporter's address and email. Patient's initial was updated. On 16-Jul-2021: Follow up received on 16 JULY 2021 and Event outcome updated
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Low grade fever of 99 degrees; A little nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever of 99 degrees) and NAUSEA (A little nauseated) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for Blood pressure high.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PYREXIA (Low grade fever of 99 degrees) and NAUSEA (A little nauseated). On 01-Feb-2021, PYREXIA (Low grade fever of 99 degrees) and NAUSEA (A little nauseated) had resolved. Not Provided          Additional concomitant product used included high cholesterol medications NOS.   This case was linked to US-MODERNATX, INC.-MOD-2021-054525 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054525:2nd dose
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Injection side was warm; Injection side was itchy; "Large red big circle" in injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site). The patient was treated with CORTISONE for Vaccination site pruritus, Vaccination site erythema and Vaccination site warmth, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  The patient used cortisone cream as treatment, but the symptoms still did not go away.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Oral pain, Oropharyngeal pain, Peripheral swelling, Vaccination site urticaria
Clinical narrative: Arms started swelling; Big red welt right around the injection site; Started to feel cruddy for a few days; Really sore throat and mouth; Really sore throat and mouth; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Started to feel cruddy for a few days), OROPHARYNGEAL PAIN (Really sore throat and mouth), ORAL PAIN (Really sore throat and mouth), PERIPHERAL SWELLING (Arms started swelling) and VACCINATION SITE URTICARIA (Big red welt right around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced MALAISE (Started to feel cruddy for a few days). 17-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Really sore throat and mouth) and ORAL PAIN (Really sore throat and mouth). On 22-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arms started swelling) and VACCINATION SITE URTICARIA (Big red welt right around the injection site). At the time of the report, MALAISE (Started to feel cruddy for a few days), OROPHARYNGEAL PAIN (Really sore throat and mouth), ORAL PAIN (Really sore throat and mouth), PERIPHERAL SWELLING (Arms started swelling) and VACCINATION SITE URTICARIA (Big red welt right around the injection site) outcome was unknown. Not Provided          Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-054475 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling cold, Headache, Limb discomfort
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state) and ASTHENIA (Weak) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044R21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder (Had a Thyroid issue.) and COVID-19 (Had COVID in July.) in July 2020. Concurrent medical conditions included Eczema (eczema from childhood.   worsening cut on fingers), Degenerative bone disease (undergoing PT for pain) since 2015 and Blood pressure high. Concomitant products included LOSARTAN for Blood pressure high, LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) for Hypothyroidism.    On 22-Mar-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state), ASTHENIA (Weak), VACCINATION SITE WARMTH (Injection site warmness), FATIGUE (Fatigue) and HEADACHE (Head is killing me). 22-Mar-2021, the patient experienced FEELING COLD (I was so cold) and VACCINATION SITE ERYTHEMA (Injection site red in color). On 24-Mar-2021, LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state), ASTHENIA (Weak), FEELING COLD (I was so cold), VACCINATION SITE WARMTH (Injection site warmness), VACCINATION SITE ERYTHEMA (Injection site red in color), FATIGUE (Fatigue) and HEADACHE (Head is killing me) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-135260, MOD-2021-054796 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Follow-up information received included patient demographics, concurrent conditions, concomitant medications, addition of new event and the outcome of the event..
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nightmare, Palpitations, Poor quality sleep, Vaccination site erythema, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state) and ASTHENIA (Weak) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044R21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder (Had a Thyroid issue.) and COVID-19 (Had COVID in July.) in July 2020. Concurrent medical conditions included Eczema (eczema from childhood.   worsening cut on fingers), Degenerative bone disease (undergoing PT for pain) since 2015 and Blood pressure high. Concomitant products included LOSARTAN for Blood pressure high, LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) for Hypothyroidism.    On 22-Mar-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state), ASTHENIA (Weak), VACCINATION SITE WARMTH (Injection site warmness), FATIGUE (Fatigue) and HEADACHE (Head is killing me). 22-Mar-2021, the patient experienced FEELING COLD (I was so cold) and VACCINATION SITE ERYTHEMA (Injection site red in color). On 24-Mar-2021, LIMB DISCOMFORT (Arm killing me), PALPITATIONS (Heart was pounding), POOR QUALITY SLEEP (I didn't sleep well), NIGHTMARE (I felt like I was in a dream state), ASTHENIA (Weak), FEELING COLD (I was so cold), VACCINATION SITE WARMTH (Injection site warmness), VACCINATION SITE ERYTHEMA (Injection site red in color), FATIGUE (Fatigue) and HEADACHE (Head is killing me) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-135260, MOD-2021-054796 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Follow-up information received included patient demographics, concurrent conditions, concomitant medications, addition of new event and the outcome of the event..
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills
Clinical narrative: Loss of equlibrium; Chills, shivering and shaking; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Loss of equlibrium) and CHILLS (Chills, shivering and shaking) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A. and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced BALANCE DISORDER (Loss of equlibrium) and CHILLS (Chills, shivering and shaking). At the time of the report, BALANCE DISORDER (Loss of equlibrium) and CHILLS (Chills, shivering and shaking) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  Concomitant product used was not provided by the reporter. Treatment information was not provided by the reporter.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Elevated heart rate; This spontaneous case was reported by an other health care professional and describes the occurrence of HEART RATE INCREASED (Elevated heart rate) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate). At the time of the report, HEART RATE INCREASED (Elevated heart rate) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow-up information received on 23-Mar-2021 included no new information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphonia, Oropharyngeal pain, Vomiting
Clinical narrative: Sore throat and hoarseness; Sore throat and hoarseness; Vomiting all throughout the night and into the following day; Chest heaviness and described it "as if I was having a heart attack."; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack."), OROPHARYNGEAL PAIN (Sore throat and hoarseness), DYSPHONIA (Sore throat and hoarseness) and VOMITING (Vomiting all throughout the night and into the following day) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack.") and VOMITING (Vomiting all throughout the night and into the following day). On 23-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat and hoarseness) and DYSPHONIA (Sore throat and hoarseness). At the time of the report, CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack."), OROPHARYNGEAL PAIN (Sore throat and hoarseness) and DYSPHONIA (Sore throat and hoarseness) outcome was unknown and VOMITING (Vomiting all throughout the night and into the following day) had resolved.            Concomitant product used was not provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever of 102). At the time of the report, PYREXIA (Fever of 102) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 102 (High) Fever of 102..         Concomitant product used was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site reaction
Clinical narrative: Itchy rash at injection site; Itchy rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash at injection site) and VACCINATION SITE REACTION (Itchy rash at injection site) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROXYCARBAMIDE (HYDROXYUREA EURECO PHARMA), GLIPIZIDE, CARVEDILOL (CARVEDILOL +PHARMA), LISINOPRIL and ATORVASTATIN for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash at injection site) and VACCINATION SITE REACTION (Itchy rash at injection site). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itchy rash at injection site) and VACCINATION SITE REACTION (Itchy rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Sunburn, Vaccination site reaction
Clinical narrative: Covid arm came and went; Sunburn that came and went; Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm came and went), SUNBURN (Sunburn that came and went) and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm came and went), SUNBURN (Sunburn that came and went) and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck). At the time of the report, VACCINATION SITE REACTION (Covid arm came and went) and SUNBURN (Sunburn that came and went) had resolved and LYMPHADENOPATHY (Patient is experiencing swelling of her lymph nodes, on the right arm, up to the base of her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.